1. Zhu Z, Huangfu D. Human pluripotent stem cells: an emerging model in developmental biology. Development. 2013; 140(4): 705–17.
2. Menendez P, Wang L, Bhatia M. Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications. Curr Gene Ther. 2005; 5(4): 375–85.
3. Xie X, Cao F, Sheikh AY, Li Z, et al. Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells. 2007; 9(1): 549–63.
4. Furuya M, Yasuchika K, Mizutani K-I, Yoshimura Y, et al. Electroporation of cynomolgus monkey embryonic stem cells. Genesis. 2003; 37: 180–7.
5. Lakshmipathy U, Pelacho B, Sudo K, Linehan JL, et al. Efficient transfection of embryonic and adult stem cells. Stem Cells. 2004; 22(4): 531–43.
6. Lorenz P, Harnack U, Morgenstern R. Efficient gene transfer into murine embryonic stem cells by nucleofection. Biotechnol Lett. 2004; 26(20): 1589–92.
7. McLenachan S, Sarsero JP, Ioannou P a. Flow-cytometric analysis of mouse embryonic stem cell lipofection using small and large DNA constructs. Genomics. 2007; 89(6): 708–20.
8. Ribeiro SC, Mendes R, Madeira C, Monteiro G a, et al. A quantitative method to evaluate mesenchymal stem cell lipofection using real-time PCR. Biotechnol Prog. 2010; 26(5): 1501–4.
9. Chung S, Andersson T, Sonntag K-C, Björklund L, et al. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells. 2002 Jan; 20(2): 139–45.
10. Eiges R, Schuldiner M, Drukker M, Yanuka O, et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol. 2001; 11:514–8.
11. Zwaka TP, Thomson J a. Homologous recombination in human embryonic stem cells. Nat Biotechnol. 2003; 21(3): 319–21.
12. Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. Biochem J. 2012; 443(3): 603–18.
13. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol. 2007; 36(3): 184–204.
14. Somers A, Jean JC, Sommer C a, Omari A, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010; 28(10): 1728–40.
15. Hong S, Hwang D-Y, Yoon S, Isacson O, et al. Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther. 2007 Sep; 15(9): 1630–9.
16. Schumacher A, Koetsier P a, Hertz J, Doerfler W. Epigenetic and genotype-specific effects on the stability of de novo imposed methylation patterns in transgenic mice. J Biol Chem. 2000; 275(48): 37915–21.
17. Dietz-Pfeilstetter A. Stability of transgene expression as a challenge for genetic engineering. Plant Sci. Elsevier Ireland Ltd; 2010; 179(3): 164–7.
18. Li M, Liu G-H, Belmonte JCI. Navigating the epigenetic landscape of pluripotent stem cells. Nat
Rev Mol Cell Biol. 2012; 13(8): 524–35.
19. Lund RJ, Närvä E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet. Nature Publishing Group; 2012; 13(9): 732–44.
20. Efe J a, Ding S. The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1575): 2208–21.
21. You JS, Han JH. Targeting components of epigenome by small molecules. Arch Pharm Res. 2014; 37(11): 1367–74.
22. Knapp S, Weinmann H. Small-molecule modulators for epigenetics targets. ChemMedChem. 2013; 8:1885–91.
23. Issa JPJ, Kantarjian HM. Targeting DNA methylation. Clinical Cancer Research. 2009; 15(12): 3938–46.
24. Kubicek S, O’Sullivan RJ, August EM, Hickey ER, et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell. 2007 Feb 9; 25(3): 473–81.
25. Miranda TB, Cortez CC, Yoo CB, Liang G, et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther. 2009 Jun; 8(6): 1579–88.
26. Tan J, Yang X, Zhuang L, Jiang X, et al. Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007; 21(9): 1050–63.
27. Hassani S-N, Totonchi M, Farrokhi A, Taei A, et al. Simultaneous suppression of TGF-β and ERK signaling contributes to the highly efficient and reproducible generation of mouse embryonic stem cells from previously considered refractory and non-permissive strains. Stem Cell Rev. 2012 Jun; 8(2): 472–81.
28. Hassani SN, Totonchi M, Sharifi-Zarchi A, Mollamohammadi S, et al. Inhibition of TGFβ Signaling Promotes Ground State Pluripotency. Stem Cell Rev Reports. 2014 Sep 15; 10(1): 16–30.
29. Rassouli H, Nemati S, Rezaeiani S, Sayadmanesh A, et al. Cloning, expression, and functional characterization of in-house prepared human leukemia inhibitory factor. Cell J. 2013; 15(2): 190–7.
30. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013; 14(3): 204–20.
31. Boyer L a, Plath K, Zeitlinger J, Brambrink T, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006 May 18; 441(7091): 349–53.
32. Mikkelsen TS, Ku M, Jaffe DB, Issac B, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007 Aug 2; 448(7153): 553–60.
33. Kang Y-K. SETDB1 in Early Embryos and Embryonic Stem Cells. Curr Issues Mol Biol. 2014; 17:1–10.
34. Kosaka Y, Kobayashi N, Fukazawa T, Totsugawa T, et al. Lentivirus-based gene delivery in mouse embryonic stem cells. Artif Organs. 2004 Mar; 28(3): 271–7.
35. Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A. 2002; 99: 2140–5.
36. Zhang B, Metharom P, Jullie H, Ellem KA, et al. The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events. Genet Vaccines Ther. 2004; 2:6.
37. Xia X, Zhang Y, Zieth CR, Zhang S. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 2007; 16(1): 167–76.
38. Ma Y, Ramezani A, Lewis R, Hawley RG, et al. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells. 2003; 21(1): 111–7.
39. Kawabata K, Sakurai F, Yamaguchi T, Hayakawa T, et al. Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol Ther. 2005 Sep; 12(3): 547–54.
40. Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, et al. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA. 2010; 16(2): 324–37.
41. Ward CM, Stern PL. The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells. Stem Cells. 2002; 20(5): 472–5.
42. Swindle CS, Klug CA. Mechanisms that regulate silencing of gene expression from retroviral vectors. J Hematother Stem Cell Res. 2002; 11(3): 449–56.
43. Hofmann A, Kessler B, Ewerling S, Kabermann A, et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol Ther. 2006; 13: 59–66.
44. Friedman J, Cho W-K, Chu CK, Keedy KS, et al. Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2. J Virol. 2011; 85(17): 9078–89.
45. Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002; 21(35): 5483–95.
46. Shi Y, Desponts C, Do JT, Hahm HS, et al. Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds. Cell Stem Cell. 2008; 3(5): 568–74.
47. Mikkelsen TS, Hanna J, Zhang X, Ku M, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature. 2008; 454(7200): 49–55.